A Field Trial to Assess a Blood-Stage Malaria Vaccine | Zendy

Mahamadou A. Théra | Zendy; Ogobara K. Doumbo | Zendy; Drissa Coulibaly | Zendy; Matthew B. Laurens | Zendy; Amed Ouattara | Zendy; Abdoulaye K. Koné | Zendy; Ando B. Guindo | Zendy; Karim Traoré | Zendy; Idrissa Traoré | Zendy; Bouréma Kouriba | Zendy; Dapa A. Diallo | Zendy; Issa Diarra | Zendy; Modibo Daou | Zendy; Amagana Dolo | Zendy; Youssouf Tolo | Zendy; Mahamadou S. Sissoko | Zendy; Amadou Niangaly | Zendy; Mady Sissoko | Zendy; Shan TakalaHarrison | Zendy; Kirsten E. Lyke | Zendy; Yukun Wu | Zendy; William C. Blackwelder | Zendy; Olivier Godeaux | Zendy; Johan Vekemans | Zendy; MarieClaude Dubois | Zendy; W. Ripley Ballou | Zendy; Joe Cohen | Zendy; Darby Thompson | Zendy; Tina Dube | Zendy; Lorraine Soisson | Zendy; Carter L. Diggs | Zendy; Brent House | Zendy; David E. Lanar | Zendy; Sheetij Dutta | Zendy; D. Gray Heppner | Zendy; Christopher V. Plowe | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Field Trial to Assess a Blood-Stage Malaria Vaccine

Author(s) -

Mahamadou A. Théra,

Ogobara K. Doumbo,

Drissa Coulibaly,

Matthew B. Laurens,

Amed Ouattara,

Abdoulaye K. Koné,

Ando B. Guindo,

Karim Traoré,

Idrissa Traoré,

Bouréma Kouriba,

Dapa A. Diallo,

Issa Diarra,

Modibo Daou,

Amagana Dolo,

Youssouf Tolo,

Mahamadou S. Sissoko,

Amadou Niangaly,

Mady Sissoko,

Shan TakalaHarrison,

Kirsten E. Lyke,

Yukun Wu,

William C. Blackwelder,

Olivier Godeaux,

Johan Vekemans,

MarieClaude Dubois,

W. Ripley Ballou,

Joe Cohen,

Darby Thompson,

Tina Dube,

Lorraine Soisson,

Carter L. Diggs,

Brent House,

David E. Lanar,

Sheetij Dutta,

D. Gray Heppner,

Christopher V. Plowe

Publication year - 2011

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1008115

Subject(s) - immunogenicity , malaria , medicine , plasmodium falciparum , malaria vaccine , virology , immunology , stage (stratigraphy) , antigen , biology , paleontology

Blood-stage malaria vaccines are intended to prevent clinical disease. The malaria vaccine FMP2.1/AS02(A), a recombinant protein based on apical membrane antigen 1 (AMA1) from the 3D7 strain of Plasmodium falciparum, has previously been shown to have immunogenicity and acceptable safety in Malian adults and children.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research